L-Carnitine Protective Effect in Nephrotoxicity
Recruiting
Phase 2
Interventional Study
Nephrotoxicity
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 46 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to assess the possible reno-protective effect of L-carnitine against cisplatin-induced nephrotoxicity in patients receiving cisplatin-based chemotherapy. The main question it aims to answer is: Does L-carnitine have the ability to protect the kidney against cisplatin-induced nephrotoxicity?
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female patients.
* Newly diagnosed patients with cancer and with an indication for cisplatin - based chemotherapy.
* Age between 18 and 75 years.
* No serious cardiopulmonary comorbidity which could impair involvement in the study.
* Creatinine clearance value above 50…
Contacts